Delivery of molecular and cellular medicine to solid tumors
- PMID: 11259838
- DOI: 10.1016/s0169-409x(00)00131-9
Delivery of molecular and cellular medicine to solid tumors
Abstract
To reach cancer cells in a tumor, a blood-borne therapeutic molecule or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium, and finally migrate through the interstitium. Unfortunately, tumors often develop in ways that hinder each of these steps. Our research goals are to analyze each of these steps experimentally and theoretically, and then integrate the resulting information in a unified theoretical framework. This paradigm of analysis and synthesis has allowed us to obtain a better understanding of physiological barriers in solid tumors, and to develop novel strategies to exploit and/or to overcome these barriers for improved cancer detection and treatment.
Similar articles
-
Delivery of molecular and cellular medicine to solid tumors.J Control Release. 1998 Apr 30;53(1-3):49-67. doi: 10.1016/s0168-3659(97)00237-x. J Control Release. 1998. PMID: 9741913 Review.
-
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function.J Control Release. 2001 Jul 6;74(1-3):7-25. doi: 10.1016/s0168-3659(01)00306-6. J Control Release. 2001. PMID: 11489479 Review.
-
Delivery of molecular and cellular medicine to solid tumors.Adv Drug Deliv Rev. 1997 Jul 7;26(2-3):71-90. doi: 10.1016/s0169-409x(97)00027-6. Adv Drug Deliv Rev. 1997. PMID: 10837535
-
Delivery of molecular and cellular medicine to solid tumors.Adv Drug Deliv Rev. 2012 Dec 1;64(Suppl):353-365. doi: 10.1016/j.addr.2012.09.011. Adv Drug Deliv Rev. 2012. PMID: 24511174 Free PMC article.
-
The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors.Microcirculation. 1997 Mar;4(1):1-23. doi: 10.3109/10739689709148314. Microcirculation. 1997. PMID: 9110280 Review.
Cited by
-
Advances and challenges in immunoPET methodology.Front Nucl Med. 2024 Feb 19;4:1360710. doi: 10.3389/fnume.2024.1360710. eCollection 2024. Front Nucl Med. 2024. PMID: 39355220 Free PMC article. Review.
-
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy.Front Pharmacol. 2023 Sep 18;14:1274088. doi: 10.3389/fphar.2023.1274088. eCollection 2023. Front Pharmacol. 2023. PMID: 37790810 Free PMC article. Review.
-
The mirrored cationic peptide as miRNA vehicle for efficient lung cancer therapy.MedComm (2020). 2023 Jul 28;4(4):e273. doi: 10.1002/mco2.273. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37521428 Free PMC article.
-
Current advances in nanodrug delivery systems for malaria prevention and treatment.Discov Nano. 2023 Apr 20;18(1):66. doi: 10.1186/s11671-023-03849-x. Discov Nano. 2023. PMID: 37382765 Free PMC article. Review.
-
Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer.Front Oncol. 2023 May 23;13:1125868. doi: 10.3389/fonc.2023.1125868. eCollection 2023. Front Oncol. 2023. PMID: 37287910 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources